Atlas Trials

Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris

Clinical trial NCT02556788 · COMPLETED

Trial details

NCT number
NCT02556788
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2015-11-01
Primary completion
2017-02-07
Enrollment
1212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.